BARCLAYS PLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 49 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2020$12,000
-7.7%
12,0000.0%0.00%
Q2 2020$13,000
-94.2%
12,000
-93.9%
0.00%
Q3 2019$226,000
-73.5%
198,000
-72.4%
0.00%
-100.0%
Q2 2019$852,000
-61.8%
718,000
-66.2%
0.00%
-50.0%
Q3 2018$2,229,000
+124.5%
2,123,000
+110.0%
0.00%
+100.0%
Q2 2018$993,000
+341.3%
1,011,000
+343.4%
0.00%
Q1 2018$225,000
-32.4%
228,000
-27.6%
0.00%
Q4 2017$333,000
-35.1%
315,000
-42.8%
0.00%
-100.0%
Q3 2016$513,000
-82.0%
551,000
-86.3%
0.00%
-75.0%
Q2 2016$2,846,000
+136.0%
4,026,000
+203.8%
0.00%
+100.0%
Q1 2016$1,206,0001,325,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2020
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders